Overcoming Challenges Faced During Gene Therapy Development for COVID-19

The world is fighting an outbreak of respiratory disease, COVID-19, caused by the SARS-CoV-2 virus. Pharmaceutical companies worldwide have worked very hard and come up with vaccinations to treat and prevent the disease. Although vaccines developed are highly efficient in preventing the disease’s adverse events but still not for the treatment. On the other hand, cell and gene therapies are promising life-changing treatments for several death-causing diseases. Our team tried to focus on some key challenges that a company could face during the development of gene therapy for COVID-19 treatment and possible ways to overcome those in this whitepaper.